Literature DB >> 25475880

Cluster randomised crossover trials with binary data and unbalanced cluster sizes: application to studies of near-universal interventions in intensive care.

Andrew B Forbes1, Muhammad Akram2, David Pilcher3, Jamie Cooper4, Rinaldo Bellomo4.   

Abstract

BACKGROUND: Cluster randomised crossover trials have been utilised in recent years in the health and social sciences. Methods for analysis have been proposed; however, for binary outcomes, these have received little assessment of their appropriateness. In addition, methods for determination of sample size are currently limited to balanced cluster sizes both between clusters and between periods within clusters. This article aims to extend this work to unbalanced situations and to evaluate the properties of a variety of methods for analysis of binary data, with a particular focus on the setting of potential trials of near-universal interventions in intensive care to reduce in-hospital mortality.
METHODS: We derive a formula for sample size estimation for unbalanced cluster sizes, and apply it to the intensive care setting to demonstrate the utility of the cluster crossover design. We conduct a numerical simulation of the design in the intensive care setting and for more general configurations, and we assess the performance of three cluster summary estimators and an individual-data estimator based on binomial-identity-link regression.
RESULTS: For settings similar to the intensive care scenario involving large cluster sizes and small intra-cluster correlations, the sample size formulae developed and analysis methods investigated are found to be appropriate, with the unweighted cluster summary method performing well relative to the more optimal but more complex inverse-variance weighted method. More generally, we find that the unweighted and cluster-size-weighted summary methods perform well, with the relative efficiency of each largely determined systematically from the study design parameters. Performance of individual-data regression is adequate with small cluster sizes but becomes inefficient for large, unbalanced cluster sizes. When outcome prevalences are 6% or less and the within-cluster-within-period correlation is 0.05 or larger, all methods display sub-nominal confidence interval coverage, with the less prevalent the outcome the worse the coverage. LIMITATIONS: As with all simulation studies, conclusions are limited to the configurations studied. We confined attention to detecting intervention effects on an absolute risk scale using marginal models and did not explore properties of binary random effects models.
CONCLUSION: Cluster crossover designs with binary outcomes can be analysed using simple cluster summary methods, and sample size in unbalanced cluster size settings can be determined using relatively straightforward formulae. However, caution needs to be applied in situations with low prevalence outcomes and moderate to high intra-cluster correlations.
© The Author(s) 2014.

Keywords:  Cluster randomised trial; binary data; crossover; intra-cluster correlation; sample size

Mesh:

Year:  2014        PMID: 25475880     DOI: 10.1177/1740774514559610

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  12 in total

1.  The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality.

Authors:  Sarah J Arnup; Andrew B Forbes; Brennan C Kahan; Katy E Morgan; Joanne E McKenzie
Journal:  Trials       Date:  2016-12-06       Impact factor: 2.279

2.  Improved survival in critically ill patients: are large RCTs more useful than personalized medicine? Yes.

Authors:  Rinaldo Bellomo; Giovanni Landoni; Paul Young
Journal:  Intensive Care Med       Date:  2016-09-12       Impact factor: 17.440

Review 3.  Review of Recent Methodological Developments in Group-Randomized Trials: Part 2-Analysis.

Authors:  Elizabeth L Turner; Melanie Prague; John A Gallis; Fan Li; David M Murray
Journal:  Am J Public Health       Date:  2017-05-18       Impact factor: 9.308

4.  Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial.

Authors:  Verinder S Sidhu; Thu-Lan Kelly; Nicole Pratt; Stephen E Graves; Rachelle Buchbinder; Sam Adie; Kara Cashman; Ilana Ackerman; Durga Bastiras; Roger Brighton; Alexander W R Burns; Beng Hock Chong; Ornella Clavisi; Maggie Cripps; Mark Dekkers; Richard de Steiger; Michael Dixon; Andrew Ellis; Elizabeth C Griffith; David Hale; Amber Hansen; Anthony Harris; Raphael Hau; Mark Horsley; Dugal James; Omar Khorshid; Leonard Kuo; Peter Lewis; David Lieu; Michelle Lorimer; Samuel MacDessi; Peter McCombe; Catherine McDougall; Jonathan Mulford; Justine Maree Naylor; Richard S Page; John Radovanovic; Michael Solomon; Rami Sorial; Peter Summersell; Phong Tran; William L Walter; Steve Webb; Chris Wilson; David Wysocki; Ian A Harris
Journal:  JAMA       Date:  2022-08-23       Impact factor: 157.335

5.  Power and sample size requirements for GEE analyses of cluster randomized crossover trials.

Authors:  Fan Li; Andrew B Forbes; Elizabeth L Turner; John S Preisser
Journal:  Stat Med       Date:  2018-10-08       Impact factor: 2.373

6.  Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.

Authors:  Paul J Young; Sean M Bagshaw; Andrew B Forbes; Alistair D Nichol; Stephen E Wright; Michael Bailey; Rinaldo Bellomo; Richard Beasley; Kathy Brickell; Glenn M Eastwood; David J Gattas; Frank van Haren; Edward Litton; Diane M Mackle; Colin J McArthur; Shay P McGuinness; Paul R Mouncey; Leanlove Navarra; Dawn Opgenorth; David Pilcher; Manoj K Saxena; Steve A Webb; Daisy Wiley; Kathryn M Rowan
Journal:  JAMA       Date:  2020-02-18       Impact factor: 56.272

7.  Understanding the cluster randomised crossover design: a graphical illustraton of the components of variation and a sample size tutorial.

Authors:  Sarah J Arnup; Joanne E McKenzie; Karla Hemming; David Pilcher; Andrew B Forbes
Journal:  Trials       Date:  2017-08-15       Impact factor: 2.279

8.  CRISTAL: protocol for a cluster randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study.

Authors:  Verinder Singh Sidhu; Steven E Graves; Rachelle Buchbinder; Justine Maree Naylor; Nicole L Pratt; Richard S de Steiger; Beng H Chong; Ilana N Ackerman; Sam Adie; Anthony Harris; Amber Hansen; Maggie Cripps; Michelle Lorimer; Steve Webb; Ornella Clavisi; Elizabeth C Griffith; Durga Anandan; Grace O'Donohue; Thu-Lan Kelly; Ian A Harris
Journal:  BMJ Open       Date:  2019-11-06       Impact factor: 2.692

9.  A tutorial on sample size calculation for multiple-period cluster randomized parallel, cross-over and stepped-wedge trials using the Shiny CRT Calculator.

Authors:  Karla Hemming; Jessica Kasza; Richard Hooper; Andrew Forbes; Monica Taljaard
Journal:  Int J Epidemiol       Date:  2020-06-01       Impact factor: 7.196

10.  Why physiology will continue to guide the choice between balanced crystalloids and normal saline: a systematic review and meta-analysis.

Authors:  Charlotte L Zwager; Pieter Roel Tuinman; Harm-Jan de Grooth; Jos Kooter; Hans Ket; Lucas M Fleuren; Paul W G Elbers
Journal:  Crit Care       Date:  2019-11-21       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.